72% of Attempts at Intercourse in the First 15 Minutes were Successful MOUNTAIN VIEW, Calif., Jan 11, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS,Inc. (Nasdaq: VVUS) today announced new data ...

VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile MOUNTAIN VIEW, Calif., Nov 18, 2009 /PRNewswire ...

SaveHealth reports that choosing an erectile dysfunction medication involves comparing effectiveness, side effects, and costs, emphasizing generics for affordability.

NEW YORK, March 18, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Petros or the Company) (NASDAQ: PTPI), a leading provider of therapeutics for men's health, today announced the publication of ...

NEW YORK, Jan. 18, 2022 /PRNewswire/ -- Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (Nasdaq: PTPI), a leading provider of therapeutics for men's health, has initiated two self-selection ...

TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has filed a New Drug Submission (“NDS”) for Avanafil with Health Canada.

VIVUS Announces Study Results Showing STENDRA (Avanafil) is Effective for Sexual Activity Within 15 Minutes in Men With Erectile Dysfunction (ED) Data From Successful Placebo-Controlled Study to be ...

Co says drug avanafil improved erectile function Drug effective in 15 min and beyond 6 hours after dosing Shares up 5 pct in pre-mkt trade June 7 (Reuters) - Vivus Inc said a second late-stage study ...

TORONTO--(BUSINESS WIRE)--Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) (“Acerus” or the “Company”) today announced that Health Canada has completed the initial screening process for the ...

NEW YORK, July 27, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI) ("Petros," or "the Company"), a leading provider of therapeutics for men's health, today announces it has been ...